ADS · CUSIP 881624209 · who reports it, how much, and how much it matters to them
39 of the 720 hedge fund managers we track reported shares of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) on Form 13F for 30 June 2026. Between them they reported USD 940m. The largest position belongs to Polar Capital LLP, at USD 177m. The manager with the most riding on it is Bridger Management, where it is 8.3% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Polar Capital LLP26 funds on PPLI.com | USD 177m | 0.4% |
| 2 | Glenview Capital Management9 funds on PPLI.com | USD 172m | 3.1% |
| 3 | Millennium Management6 funds on PPLI.com | USD 111m | 0.0% |
| 4 | Dme Capital Management7 funds on PPLI.com | USD 98m | 2.5% |
| 5 | Adage Capital Management1 fund on PPLI.com | USD 80m | 0.1% |
| 6 | Sphera Funds Management1 fund on PPLI.com | USD 51m | 6.6% |
| 7 | Bridgewater Associates45 funds on PPLI.com | USD 45m | 0.2% |
| 8 | POINT72 Asset Management17 funds on PPLI.com | USD 36m | 0.0% |
| 9 | Freestone Grove Partners1 fund on PPLI.com | USD 20m | 0.1% |
| 10 | LMR Partners2 funds on PPLI.com | USD 20m | 0.1% |
| 11 | Tudor Investment Corporation10 funds on PPLI.com | USD 17m | 0.0% |
| 12 | Ardsley Advisory Partners6 funds on PPLI.com | USD 16m | 1.6% |
| 13 | Atika Capital Management3 funds on PPLI.com | USD 15m | 1.0% |
| 14 | Bridger Management3 funds on PPLI.com | USD 12m | 8.3% |
| 15 | IFM Investors Pty7 funds on PPLI.com | USD 9.5m | 0.1% |
| 16 | Continental Advisors1 fund on PPLI.com | USD 7.9m | 3.3% |
| 17 | Two Sigma Investments35 funds on PPLI.com | USD 7.8m | 0.0% |
| 18 | D. E. Shaw & Co.15 funds on PPLI.com | USD 6.1m | 0.0% |
| 19 | Holocene Advisors2 funds on PPLI.com | USD 5.7m | 0.0% |
| 20 | CIBC Asset Management69 funds on PPLI.com | USD 5.4m | 0.0% |
| 21 | Prelude Capital Management9 funds on PPLI.com | USD 5.3m | 0.4% |
| 22 | Lighthouse Investment Partners190 funds on PPLI.com | USD 3.3m | 0.1% |
| 23 | Boothbay Fund Management2 funds on PPLI.com | USD 3.1m | 0.0% |
| 24 | Greenland Capital Management1 fund on PPLI.com | USD 2.7m | 0.3% |
| 25 | Citadel Advisors32 funds on PPLI.com | USD 2.5m | 0.0% |
| 26 | Gamco Asset Management1 fund on PPLI.com | USD 2.2m | 0.0% |
| 27 | Rock Springs Capital Management2 funds on PPLI.com | USD 2m | 0.1% |
| 28 | Squarepoint Ops7 funds on PPLI.com | USD 2m | 0.0% |
| 29 | Steinberg Asset Management2 funds on PPLI.com | USD 1.5m | 0.9% |
| 30 | Farallon Capital Management56 funds on PPLI.com | USD 1.4m | 0.0% |
| 31 | Alpine Woods Capital Investors3 funds on PPLI.com | USD 1.3m | 0.3% |
| 32 | Exoduspoint Capital Management7 funds on PPLI.com | USD 953,000 | 0.0% |
| 33 | Gabelli & Company Investment Advisers17 funds on PPLI.com | USD 407,000 | 0.1% |
| 34 | Brevan Howard Capital Management39 funds on PPLI.com | USD 339,000 | 0.0% |
| 35 | Verition Fund Management3 funds on PPLI.com | USD 293,000 | 0.0% |
| 36 | Elequin Capital2 funds on PPLI.com | USD 41,605 | 0.0% |
| 37 | Bayforest Capital1 fund on PPLI.com | USD 32,220 | 0.0% |
| 38 | Graticule Asia Macro Advisors8 funds on PPLI.com | USD 11,384 | 0.0% |
| 39 | Wolverine Asset Management1 fund on PPLI.com | USD 34 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Bridger Management | USD 12m | 8.3% |
| 2 | Sphera Funds Management | USD 51m | 6.6% |
| 3 | Continental Advisors | USD 7.9m | 3.3% |
| 4 | Glenview Capital Management | USD 172m | 3.1% |
| 5 | Dme Capital Management | USD 98m | 2.5% |
| 6 | Ardsley Advisory Partners | USD 16m | 1.6% |
| 7 | Atika Capital Management | USD 15m | 1.0% |
| 8 | Steinberg Asset Management | USD 1.5m | 0.9% |
| 9 | Polar Capital LLP | USD 177m | 0.4% |
| 10 | Prelude Capital Management | USD 5.3m | 0.4% |
Teva Pharmaceutical Industries Ltd trades under the symbol TEVA on the New York Stock Exchange. Its CUSIP, the code used on Form 13F, is 881624209.
39 of the 720 hedge fund managers PPLI.com tracks reported Teva Pharmaceutical Industries Ltd shares on Form 13F for 30 June 2026. The largest reported positions were held by Polar Capital LLP (USD 177m), Glenview Capital Management (USD 172m), Millennium Management (USD 111m), Dme Capital Management (USD 98m) and Adage Capital Management (USD 80m).
39 managers in our coverage reported it, and between them they run 649 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Bridger Management, where the position was 8.3% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Teva Pharmaceutical Industries Ltd or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.